The invention provides a pharmaceutical combination comprising: a) at least one agent selected from Bcr-Abl, Flt-3, FAK and RAF kinase inhibitors; and b) at least one JAK kinase inhibitor and a method for treating or preventing a proliferative disease using such a combination.
申请公布号
WO2006056399(A2)
申请公布日期
2006.06.01
申请号
WO2005EP12480
申请日期
2005.11.22
申请人
NOVARTIS AG;NOVARTIS PHARMA GMBH;COOKE, NIGEL, GRAHAM;MANLEY, PAUL, W.
